RegentAtlantic Capital’s Idexx Laboratories IDXX Stock Holding History

RegentAtlantic Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.32M	Buy	4,068 +705	+21%	+$259K	0.04%	260
2022 Q2	$1.18M	Buy	3,363 +1,880	+127%	+$767K	0.04%	286
2022 Q1	$811K	Buy	1,483 +77	+5%	+$40.5K	0.02%	356
2021 Q4	$926K	Sell	1,406 -10	-0.7%	-$6.28K	0.03%	337
2021 Q3	$881K	Buy	1,416 +194	+16%	+$130K	0.03%	327
2021 Q2	$772K	Buy	1,222 +136	+13%	+$75.1K	0.02%	334
2021 Q1	$531K	Buy	1,086 +224	+26%	+$112K	0.02%	372
2020 Q4	$431K	Buy	862 +10	+1%	+$4.47K	0.02%	363
2020 Q3	$335K	Sell	852 -2	-0.2%	-$739	0.02%	378
2020 Q2	$282K	Buy	+854	New	+$247K	0.02%	396
2015 Q1	–	Sell	-30	Closed	-$2.22K	–	597
2014 Q4	$2.22K	Buy	+30	New	+$2.1K	﹤0.01%	1117

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RegentAtlantic Capital's IDXX Position: Q3 2022 in Review

RegentAtlantic Capital increased its Idexx Laboratories (IDXX) stake by 21% in Q3 2022, buying an estimated $259K and bringing the position to 4,068 shares worth $1.32M. The position accounts for 0.04% of the portfolio, ranked #260.

RegentAtlantic Capital first reported a position in IDXX in Q4 2014 and has held it in 11 quarters since. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

RegentAtlantic Capital held 4,068 shares of Idexx Laboratories worth $1.32M as of Q3 2022.
RegentAtlantic Capital bought 705 Idexx Laboratories shares in Q3 2022, an estimated $259K.
Idexx Laboratories made up 0.04% of RegentAtlantic Capital's portfolio in Q3 2022, its #260 holding.
RegentAtlantic Capital first reported a position in Idexx Laboratories in Q4 2014 and has held it in 11 quarters since.
924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.